HCSG · Healthcare Services Group Inc · Metrics
$25.10
+0.41 (+1.66%)
At close · Nov 18
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$1.69B
Shares
67.43M
Volume · Nov 18
618.8K
Avg daily vol (3M)
692.36K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
HCSG metrics
98 of 125 screener metrics currently available.
Market overview
2 metricsShare price
$25.10
Market cap
$1.69B
Price action
23 metricsPrice change (1W)
-0.4%
Price change (30D)
+18.9%
Price change (3M)
+9.5%
Price change (6M)
+20.6%
Price change (YTD)
+31.3%
Price change (1Y)
+46.0%
Trailing year
Price change (5Y)
+32.9%
52-week high
$26.54
52-week low
$17.19
Change from 52-week high
-5.4%
Change from 52-week low
+46.0%
Annualized volatility
42.4%
Annualized volatility (3M)
38.9%
Implied volatility (30D)
42.9%
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
0.7
RSI (14D)
58.5
Price vs SMA 50
+10.5%
Price vs SMA 200
+15.1%
Avg volume (3M)
692,362
Relative volume
0.9
Average dollar volume
$15.65M
Company
3 metricsSector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
67.43M
Valuation
12 metricsP / E (TTM)
17.0
Trailing earnings · reciprocal yield 5.9%
PEG ratio
—
EV / revenue
0.8×
reciprocal yield 123.4%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.9×
reciprocal yield 111.1%
P / book
3.2
reciprocal yield 31.4%
FCF yield
6.3%
TTM · current market cap
Buyback yield
4.5%
P / FCF
15.9
reciprocal yield 6.3%
P / operating cash flow
15.0
reciprocal yield 6.7%
Earnings yield
6.2%
Historical valuation
8 metricsP / E historical average (3Y)
20.7×
reciprocal yield 4.8%
P / E historical average (5Y)
27.1×
reciprocal yield 3.7%
EV / revenue historical average (3Y)
0.6×
reciprocal yield 181.1%
EV / revenue historical average (5Y)
0.6×
reciprocal yield 176.9%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
4.5%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
0
Last ex-dividend
2022-11-17
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-10-21
Profitability
9 metricsGross margin
16.1%
Operating margin
—
Trailing 12 months
Net margin
5.6%
Gross profit (TTM)
$303.09M
Operating profit (TTM)
—
Net income (TTM)
$104.88M
Trailing 12 months
Diluted EPS (TTM)
$1.48
FCF margin
5.7%
Effective tax rate
18.0%
Growth
11 metricsRevenue growth YoY
+3.3%
Year over year
Net income growth YoY
-42.1%
Revenue (TTM)
$1.88B
Trailing 12 months
EPS growth YoY
-39.0%
Shares change YoY
-4.9%
Year over year · fewer shares
Revenue CAGR (3Y)
+2.8%
Revenue CAGR (5Y)
+0.9%
EPS CAGR (3Y)
+20.8%
EPS CAGR (5Y)
-9.3%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
-8.2%
Quality
14 metricsReturn on equity
19.7%
Return on assets
12.3%
Debt / equity
0.0
Current ratio
2.8
EBITDA (TTM)
—
Free cash flow (TTM)
$106.68M
Quick ratio
2.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$168.82M
Latest balance sheet
Cash & equivalents
$134.60M
Total assets
$850.40M
Total debt
$0
Cash flow & spend
7 metricsOperating cash flow (TTM)
$113.16M
Capital expenditures (TTM)
$6.48M
R&D (TTM)
—
SG&A (TTM)
$189.23M
Stock compensation (TTM)
$11.65M
R&D / revenue
—
Stock compensation / revenue
0.6%
Ownership (13F)
9 metrics13F filers
278
13F filer change QoQ
+1
Institutional ownership
101.6%
Conviction holders (share of 13F filers)
0.4%
Crowding (high-turnover and private-fund holders)
27.9%
Private-fund adviser ownership
26.5%
Active holders' share change QoQ
-3.7%
Holder tenure
15.4
Price vs estimated holder cost
+12.1%
Ownership (registered funds)
1 metricsIndex-fund ownership
31.7%
Short interest
3 metricsShort interest
3.7%
Latest settlement · 2.7 days to cover
Days to cover
2.7d
Short-squeeze score
59 / 100
Insider activity
2 metricsNet insider buying (90D)
−$457,981
Insider-sentiment score
36 / 100
Risk flags
1 metricsGoing concern
—
Key facts
CIK
731012
CUSIP
421906108
13F (30d)
278 filings
261 filers
Visit website
Investor relations